- Home
- TVRD vs ARL Comparison
TVRD vs ARL Comparison
Compare TVRD & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- ARL
- Stock Information
- Founded
- TVRD 2017
- ARL 1999
- Country
- TVRD United States
- ARL United States
- Employees
- TVRD N/A
- ARL N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- ARL Building operators
- Sector
- TVRD Health Care
- ARL Real Estate
- Exchange
- TVRD Nasdaq
- ARL Nasdaq
- Market Cap
- TVRD 246.5M
- ARL 245.7M
- IPO Year
- TVRD N/A
- ARL N/A
- Fundamental
- Price
- TVRD $6.73
- ARL N/A
- Analyst Decision
- TVRD Buy
- ARL
- Analyst Count
- TVRD 7
- ARL 0
- Target Price
- TVRD $51.67
- ARL N/A
- AVG Volume (30 Days)
- TVRD 467.6K
- ARL 1.2K
- Earning Date
- TVRD 11-21-2025
- ARL 11-06-2025
- Dividend Yield
- TVRD N/A
- ARL N/A
- EPS Growth
- TVRD N/A
- ARL N/A
- EPS
- TVRD N/A
- ARL N/A
- Revenue
- TVRD N/A
- ARL $48,139,000.00
- Revenue This Year
- TVRD N/A
- ARL N/A
- Revenue Next Year
- TVRD N/A
- ARL N/A
- P/E Ratio
- TVRD N/A
- ARL N/A
- Revenue Growth
- TVRD N/A
- ARL N/A
- 52 Week Low
- TVRD $5.65
- ARL $9.43
- 52 Week High
- TVRD $43.65
- ARL $18.00
- Technical
- Relative Strength Index (RSI)
- TVRD 20.91
- ARL 46.74
- Support Level
- TVRD $5.65
- ARL $14.55
- Resistance Level
- TVRD $7.11
- ARL $16.85
- Average True Range (ATR)
- TVRD 2.47
- ARL 0.47
- MACD
- TVRD -4.16
- ARL -0.20
- Stochastic Oscillator
- TVRD 3.26
- ARL 30.21
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.